Downstream Processing Featured Articles
-
Millipore's Montage DNA Gel Extraction Kit Maximizes DNA Recovery from Agarose Gel Slices
7/26/2002
10-minute spin yields fully functional DNA50 x modified TAE buffer available with the kit...
-
Element Six And The University Of Warwick Announce Development Of New Boron-Doped Synthetic Diamond Electrode For Extreme Electroanalysis Sensing Applications
3/18/2013
AT PITTCON 2013, Element Six, the world leader in synthetic diamond supermaterials and member of the De Beers Group of Companies, recently announced that it has engineered DIAFILM EA (Electroanalysis grade) in collaboration with The University of Warwick.
-
A Welcome Predictability
10/8/2012
Synthetic biology is the latest and most advanced phase of genetic engineering, holding great promise for helping to solve some of the world's most intractable problems, including the sustainable production of energy fuels and critical medical drugs, and the safe removal of toxic and radioactive waste from the environment.
-
Theratechnologies Secures US Patent For Its Novel Peptide TH1173
1/29/2013
Theratechnologies Inc. (TSX:TH)(NASDAQ:THER) today reported that the US Patent and Trademark Office (USPTO) has granted a patent (US Patent No. 8,361,964) for its second generation growth-hormone releasing factor (GRF) peptide, TH1173, providing for patent protection beyond 2030.
-
Scientists Find A New Way To Boost Common Cancer Drugs
1/14/2013
Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue of Cancer Discovery.
-
3M Purification Inc. Introduces LifeASSURE PDA Gamma Compatible And Sterile Capsule Filters
5/4/2012
3M Purification Inc. has expanded its portfolio of the LifeASSURE PDA Series of sterilizing grade polyethersulfone (PES) membrane filters.
-
Rapid Single Molecule Haplotyping
12/29/2009
A technical poster from Fluidigm Europe entitled 'Rapid single-molecule haplotyping in patients with sickle cell disease' reports upon the pioneering work of Dr Stephen Menzel and his fellow researchers at Kings College (London), School of Medicine.
-
Rare Cancers Yield Potential Source Of Tumor Growth
9/17/2012
Researchers at the National Institutes of Health have discovered a genetic mutation that appears to increase production of red blood cells in tumors.
-
Aeras Signs Agreement With GSK To Jointly Advance TB Vaccine
10/10/2012
Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK’s proprietary M72 antigen and AS01E adjuvant.
-
Damania Lab Discovers Gene That Suppresses Herpesviruses
2/14/2013
In a paper published by Cell Host and Microbe on Feb. 13, a research team led by Blossom Damania, PhD, of the Department of Microbiology and Immunology and member of the UNC Lineberger Comprehensive Cancer Center, found that suppressing the TLK enzyme causes the activation of the lytic cycle of both EBV and KSHV. During this active phase, these viruses begin to spread and replicate, and become vulnerable to anti-viral treatments.